{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-26-000917","form_type":"8-K","ticker":"SBEV","cik":"0001553788","company_name":"SPLASH BEVERAGE GROUP, INC.","filed_at":"2026-07-06T20:30:33+00:00","discovered_at":"2026-07-06T20:32:01.272619+00:00","generated_at":"2026-07-06T20:32:23.386376+00:00","sec_items":["1.01","5.03","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Splash Beverage Group acquires exclusive worldwide license for CannEpil® epilepsy drug; issues $5.5M Series D preferred","bullets":["Exclusive worldwide rights to CannEpil® (CBD/THC) for drug-resistant epilepsy; Licensor gets 15% royalty on net revenue.","SBEV issues 5,500 shares of Series D Convertible Preferred (stated value $5.5M) to Licensor's noteholder as part of consideration.","C/M Capital commits to invest at least $1M in SBEV within 60 days; also $1M sales bonus upon $5M cumulative net revenue.","Development milestones: initiate Phase I trial within 24 months, Phase II within 48 months, file NDA after successful trials.","Licensor may terminate if SBEV fails to obtain US regulatory approval within 5 years; initial term 20 years."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-000917","json":"https://secwatch.observer/filing/0001731122-26-000917.json","markdown":"https://secwatch.observer/filing/0001731122-26-000917.md","text":"https://secwatch.observer/filing/0001731122-26-000917.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000917/0001731122-26-000917-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000917/e7760_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-06T20:32:23.386376+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}